Form 4: Marimed CFO Mario Pinho Converts Restricted Stock Units, Increases Direct Holdings

Marimed Inc.'s Chief Financial Officer, Mario Pinho, converted 53,571 Restricted Stock Units (RSUs) into common stock, with a portion withheld for tax obligations, as part of a pre-scheduled compensation event.

Summary

• Mario Pinho, Chief Financial Officer of Marimed Inc. (MRMD), reported transactions involving the company's common stock and Restricted Stock Units (RSUs).
• On June 30, 2025, 53,571 RSUs were converted into shares of common stock on a one-for-one basis.
• Following the conversion, 99,084 shares of common stock were beneficially owned directly.
• Concurrently, 18,563 shares of common stock were withheld by Marimed Inc. to satisfy tax withholding obligations related to the RSU vesting, at a price of $0.0699 per share.
• After the tax withholding, the direct beneficial ownership of common stock was 80,521 shares.
• The RSUs converted were part of a grant made on February 18, 2025.
• Remaining RSUs include 53,572 units scheduled to vest on September 30, 2025, and 53,571 units on December 31, 2025.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it reflects a standard, expected compensation event for a key executive, aligning their interests with the company's performance. The tax withholding is a neutral, routine aspect of such transactions.

Positives

• The vesting and conversion of Restricted Stock Units (RSUs) represent a standard compensation event for the Chief Financial Officer, aligning management's interests with shareholder value.
• The increase in direct beneficial ownership of common stock by the CFO demonstrates continued commitment to the company.

Negatives

• A portion of the vested shares (18,563 shares) was withheld by the issuer to cover tax obligations, reducing the net shares received by the CFO.

Future Outlook

The Chief Financial Officer has additional Restricted Stock Units (RSUs) scheduled to vest, with 53,572 units vesting on September 30, 2025, and 53,571 units vesting on December 31, 2025.

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation. Such filings are common across all industries for publicly traded companies, reflecting the vesting and conversion of stock-based awards for executives and directors.

Stakeholder Impact

• Shareholders: The conversion of RSUs into common stock may result in a minor increase in the outstanding share count, which is a planned aspect of equity compensation. It also signifies continued alignment of the CFO's interests with shareholder value.
• Employees: This transaction is a standard example of executive equity compensation, which is a common component of employee incentive programs.

Next Steps

• Vesting of 53,572 Restricted Stock Units (RSUs) on September 30, 2025.
• Vesting of 53,571 Restricted Stock Units (RSUs) on December 31, 2025.

Key Dates

Keywords

MARIMED INC., MRMD, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Chief Financial Officer, Mario Pinho, Equity Compensation, Stock Holdings